Global Health has received a communication from NSE Sustainability Ratings & Analytics informing that they have assigned an ESG rating of `69` for the Financial Year 2025 to the Company. Powered by Capital Market - Live News

Net profit of Global Health declined 33.51% to Rs 95.02 crore in the quarter ended December 2025 as against Rs 142.91 crore during the previous quarter ended December 2024. Sales rose 18.83% to Rs 1121.05 crore in the quarter ended December 2025 as against Rs 943.44 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1121.05943.44 19 OPM %19.3825.20 - PBDT217.57237.51 -8 PBT156.38189.07 -17 NP95.02142.91 -34 Powered by Capital Market - Live News

Global Health will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live News

Net profit of Global Health rose 21.09% to Rs 158.44 crore in the quarter ended September 2025 as against Rs 130.84 crore during the previous quarter ended September 2024. Sales rose 14.91% to Rs 1099.22 crore in the quarter ended September 2025 as against Rs 956.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1099.22956.56 15 OPM %22.4623.86 - PBDT249.54230.53 8 PBT199.81181.10 10 NP158.44130.84 21 Powered by Capital Market - Live News

Global Health will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live News